|
Age at enrolment (years, mean ± SD)
|
23.9 (±5.7)
|
26.5 (± 6.1)
|
21.5 (5.6)
|
< 0.001
|
|
Parasite density by LM (parasites/μl, Median (IQR))
|
|
ANC-1
|
903 (324.5–2308.5)
|
–
|
1752.5 (558.5–5373.5)
|
0.01
|
|
Delivery
|
–
|
1955.7 (565.2–9733)
|
2268 (835–15,485)
|
0.84
|
|
MiP preventive strategy
|
|
IPTp-SP
|
67 (55.8)
|
58 (48.3)
|
20 (47.6)
|
0.40
|
|
CSST/IPTp-SP
|
53 (44.2)
|
62 (51.7)
|
22 (52.4)
| |
|
Gravidity
|
|
≤ 2
|
63 (52.5)
|
35 (29.2)
|
32 (76.2)
|
< 0.001
|
|
> 2
|
57 (47.5)
|
85 (70.8)
|
10 (23.8)
| |
|
ITN usagea
|
|
Night before ANC-1
|
103 (92.8)
|
–
|
24 (72.7)
|
0.004
|
|
Night before delivery
|
–
|
69 (62.2)
|
24 (72.7)
|
0.30
|
|
IPTp-SP doses during pregnancy
|
|
< 3
|
–
|
82 (68.3)
|
33 (78.6)
|
0.21
|
|
≥ 3
|
–
|
38 (31.7)
|
9 (21.4)
| |
|
AL treatment during pregnancy
|
|
0
|
–
|
67 (55.8)
|
13 (31.0)
|
0.02
|
|
1
|
–
|
33 (27.5)
|
19 (45.2)
| |
|
≥ 2
| |
20 (16.7)
|
10 (23.8)
| |
|
Timing AL treatment to delivery
|
|
No treatment
| |
67 (55.8)
|
13 (31.0)
|
0.05
|
|
4 to 28 days
|
–
|
18 (15.0)
|
8 (19.0)
| |
|
29 to 42 days
|
–
|
13 (10.8)
|
10 (23.8)
| |
|
43 to 63 days
| |
13 (10.8)
|
5 (11.9)
| |
|
≥ 64 days
| |
9 (7.5)
|
4 (14.3)
| |
|
Haemoglobin level at deliverya
|
|
< 11 g/dl
|
–
|
63 (53.4)
|
20 (50.0)
|
0.72
|
|
≥ 11 g/dl
|
–
|
55 (46.6)
|
20 (50.0)
| |
|
Malaria episode during pregnancy
|
|
≤ 2
|
–
|
58 (48.3)
|
0 (0.0)
|
< 0.001
|
|
> 2
|
–
|
62 (51.7)
|
42 (100)
| |
|
Triple dhfr 51/59/108 mutation at deliverya
|
|
No
| |
19 (28.8)
|
6 (35.3)
|
0.60
|
|
Yes
| |
46 (71.2)
|
11 (64.7)
| |
